Skip to main content
Illumina Inc.
Healthcare · Diagnostics & Research
Made on Aug 26, 2026
Price at call $226.20
6-month call Bear -12.5%
Target by Feb 2027 $198.00
Great value below $150.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -12.5% to $198.00
Predicted High $230.50 in 2 weeks
Predicted Low $198.00 at 6 months
Max Drawdown (predicted) -12.5%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 26, 2026 1:20 pm
Bear ILMN trends lower to $198.00 (-12.5% from $226.20) by Feb 2027. ride-then-fade
ThesisILMN trades far above fair value on a genomics-monopoly and cancer-vaccine narrative after an 83% six-month rip. Risk-on regime and momentum can sustain elevated prices near-term, but value gravity and profit-taking pull the path lower over the six-month window, converging toward the deterministic baseline rather than the harsh DCF.
Invalidated ifA decisive break above 250 on sustained volume, or a major MRD/cancer-vaccine catalyst that re-rates the narrative, would invalidate the fade.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $226.20 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 26, 2026 $226.20 at call The anchor — every point below is measured from this price and date.
2 weeks Sep 9, 2026 $206.89–$245.51 typical range · internal point $230.50 ±8.5% 6/10 Momentum and risk-on regime carry price higher
What actually happened: closed $211.06 on Sep 8, 2026 = -6.7% vs the call (predicted +1.9%)  ·  direction MISS (called flat, was down)  ·  off by 8.6 pp  ·  accuracy 4/10  ·  typical range ±8.5%: inside the band  ·  S&P 0.0% over the same window — lagged it
1 month Sep 26, 2026 $198.22–$254.18 typical range · internal point $228.00 ±12.4% 5/10 Narrative intact, no catalyst, mild consolidation
2 months Oct 26, 2026 $220.00 -2.7% 5/10 Profit-taking begins as momentum cools
3 months Nov 26, 2026 $212.00 -6.3% 5/10 Pre-earnings de-risking, value gravity emerges
4 months Dec 26, 2026 $215.00 -5.0% 4/10 Year-end window dressing offsets fundamentals
5 months Jan 26, 2027 $205.00 -9.4% 4/10 January reset, high-beta narrative names fade
6 months Feb 26, 2027 $198.00 -12.5% 4/10 Convergence toward deterministic baseline endpoint

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $195.44 (-13.6%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$226.20
Composite fair value$58.61
Signal-adjusted fair value$57.28
DCF fair value$44.21
Anchored-PE fair value$150.13
Buy-below (value lens)$150.00
Value net score-66
Value confidence6 / 10
Quality net score+17
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 44.9%  3m 42.9%  6m 41.3%  
Daily σ (realism noise)2.7%
Beta vs S&P 500 1m 0.23  3m 0.60  5m 0.82  
Trailing 6-month return83.1%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 26, 2026 freshest ILMN-20260826-073001-c23a
ext-forensic-memo Aug 26, 2026 freshest ext-ILMN-20260826-090752-4fd1
ext-lens-quality Aug 26, 2026 freshest ext-ILMN-20260826-090752-4fd1
ext-lens-sentiment Aug 26, 2026 freshest ext-ILMN-20260826-090752-4fd1
ext-lens-value Aug 26, 2026 freshest ext-ILMN-20260826-090752-4fd1
scenario-valuation Aug 26, 2026 freshest ILMN-20260826-073001-c23a
valuation-synthesis Aug 26, 2026 freshest ILMN-20260826-073001-c23a

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

1 frozen snapshot — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 26, 2026 v0.6.0 Bear $226.20 $198.00 -12.5% Feb 2027 viewing

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.